GSI Group receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Novanta Inc (NOVT)
Track the Novanta share price today and view real-time NOVT share price data, including charts, technicals, and key financials. View the NOVT premarket stock price ahead of the market session or assess the after hours quote. Explore NOVT stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Novanta Stock Price Today?
The Novanta stock price today is 118.88.
What Is the Stock Symbol for Novanta?
The stock symbol for Novanta is ""NOVT.""
What Stock Exchange Does Novanta Trade On?
Novanta is listed and trades on the NASDAQ stock exchange.
Is Novanta a Good Stock to Buy?
Determining whether Novanta or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NOVT quote. (ISIN: CA67000B1040)
What Is the Novanta Stock Price Today?
The Novanta stock price today is 118.88.
What Is the Stock Symbol for Novanta?
The stock symbol for Novanta is ""NOVT.""
What Stock Exchange Does Novanta Trade On?
Novanta is listed and trades on the NASDAQ stock exchange.
Is Novanta a Good Stock to Buy?
Determining whether Novanta or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NOVT quote. (ISIN: CA67000B1040)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
113.13
121.44
52 wk Range
98.27
176.38
NOVT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
113.13121.44
52 wk Range
98.27176.38
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NOVT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
185.00
Upside
+55.62%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
Why is Novanta stock tumbling today?- Investing.com
- GSI Group receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Why is Novanta stock tumbling today?
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 185.00
(+55.62% Upside)
Novanta Inc Earnings Call Summary for Q3/2026
- Novanta reported Q3 2026 adjusted EPS of $1.05 on revenue of $305M, beating estimates of $0.94 and $262.82M; shares fell 2.73% premarket.
- Adjusted EBITDA reached record $80M with 26% margin, up 38% YoY; bookings rose 29% with 1.08 book-to-bill ratio signaling strong demand.
- Q4 guidance of $306M-$312M revenue and $0.91-$0.96 EPS below Q3 due to temporary U.K. production issues and lithography shipment delays.
- Full-year 2026 revenue outlook raised to $1.135B-$1.14B; 2027 guidance projects 15%+ growth and 100+ bps gross margin expansion.
- Riverpoint Medical acquisition integrating well, supporting strategic shift toward medical exposure and recurring revenue; operating cash flow up to $156M YTD.
Last Updated: 11/11/2026, 01:00 am
Read Full TranscriptEarnings
Latest Release
09/11/2026
EPS / Forecast
1.05 / 0.94
Revenue / Forecast
305M / 262.82M
Compare NOVT to Peers and Sector
Metrics to compare | NOVT | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipNOVTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 84.6x | 50.6x | 10.9x | |
PEG Ratio | −7.97 | −4.64 | 0.01 | |
Price/Book | 2.8x | 2.0x | 2.4x | |
Price / LTM Sales | 4.1x | 1.9x | 2.0x | |
Upside (Analyst Target) | 55.6% | 46.6% | 47.3% | |
Fair Value Upside | Unlock | 13.0% | 10.1% | Unlock |
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Novanta (NOVT) Stock Price Today?
The Novanta stock price today is 118.88 USD.
What Stock Exchange Does Novanta Trade On?
Novanta is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Novanta?
The stock symbol for Novanta is "NOVT."
What Is the Novanta Market Cap?
As of today, Novanta market cap is 4.50B USD.
What Is Novanta's Earnings Per Share (TTM)?
The Novanta EPS (TTM) is 1.31.
When Is the Next Novanta Earnings Date?
Novanta will release its next earnings report on 02/03/2027.
From a Technical Analysis Perspective, Is NOVT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Novanta Stock Split?
Novanta has split 1 times.
How Many Employees Does Novanta Have?
Novanta has 3000 employees.
What is the current trading status of Novanta (NOVT)?
As of 15/11/2026, Novanta (NOVT) is trading at a price of 118.88 USD, with a previous close of 118.88 USD. The stock has fluctuated within a day range of 113.13 USD to 121.44 USD, while its 52-week range spans from 98.27 USD to 176.38 USD.
What Is Novanta (NOVT) Price Target According to Analysts?
The average 12-month price target for Novanta is 185.00 USD, with a high estimate of 195 USD and a low estimate of 175 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +55.62% Upside potential.
What Is the NOVT Premarket Price?
NOVT's last pre-market stock price is 117.84 USD. The pre-market share volume is 90.00, and the stock has decreased by 0.42, or 0.36%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.